Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Hut 8 Corp (HUT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Hut 8 Corp — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B), while Hut 8 Corp trades at $71.03 (market cap $9.23B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 3.4× Hut 8 Corp's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Hut 8 Corp pays none. Which is the better fit depends on your goals.
| GEHC | HUT | |
|---|---|---|
Market Cap | $30.93B | $9.23B |
Volume | 5,033,451 | 12,843,584 |
Sector | Health | Financials |
52-Week High | $88.16 | $133.02 |
52-Week Low | $59.48 | $33.76 |
Enterprise Value | $39.39B | $16.67B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
HUT trades at $83.61, down 1.91% on the day, amid a bearish technical signal. The company reported a net loss of $226.15 million in 2025 with a negative net income margin of 188.59%, though revenue grew to $235.12 million. Recent news highlights a $1.07 billion credit facility and positive analyst coverage, with 16 of 17 analysts rating it a buy and a consensus price target of $163.62.
The outlook is mixed: strong analyst sentiment and AI infrastructure growth potential contrast with persistent losses and high valuation ratios. Key risks include execution on profitability and sensitivity to sector volatility. The stock offers upside if operational improvements materialize but remains speculative given current financials.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Hut 8 Corp
Hut 8 is one of North America's largest digital asset miners and infrastructure providers. It operates diversified data centers supporting Bitcoin mining and high-performance computing (HPC) for AI.
Read more on HUT →
